Janis Kay Shute. (2023). Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease. MDPI AG.
Chicago Style (17th ed.) CitationJanis Kay Shute. Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease. MDPI AG, 2023.
MLA (9th ed.) CitationJanis Kay Shute. Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.